NCT00602537View on ClinicalTrials.gov

Antidepressant Therapy in Treating Bipolar Type II Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Bipolar DisorderDepression
Interventions
DRUG

Venlafaxine

75 to 375 mg

DRUG

Lithium Carbonate

300 to 2400 mg

Trial Locations (1)

19104-3309

Depression Research Unit - University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00602537 - Antidepressant Therapy in Treating Bipolar Type II Major Depression | Biotech Hunter | Biotech Hunter